Premenstrual Syndrome Treatment Market Size, Trends, Share and Forecast 2023-2028

According to the latest report by IMARC Group, titled “Premenstrual Syndrome Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” The global premenstrual syndrome treatment market size reached US$ 1,346 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,683 Million by 2028, exhibiting a growth rate (CAGR) of 3.9% during 2023-2028.

Premenstrual syndrome (PMS) refers to changes in the physical health, mood and emotions, and behavior of women before the beginning of the period. It includes symptoms, such as anxiety, depression, headache, joint pain, weight gain, pimples, angry outbursts, bloating, tiredness, and mood swings. It is caused by cyclic changes in hormones and chemical changes in the brain due to fluctuations of serotonin, which contributes to fatigue, food cravings, and sleep problems. It also occurs due to smoking, lack of physical exercise, drinking alcohol, and eating sugary and fatty products. Premenstrual syndrome can be treated by nonsteroidal anti-inflammatory drugs (NSAIDs), diuretics, antidepressants, birth control pills, or hormone-regulating pills. It can also be prevented by acupuncture, reflexology, and dietary supplements.

Request Free Sample Report: https://www.imarcgroup.com/premenstrual-syndrome-treatment-market/requestsample

Premenstrual Syndrome Treatment Market Trends and Drivers:

Presently, the rising awareness about the treatment of PMS among women, along with the increasing number of PMS treatment medications, represents one of the primary factors strengthening the market growth. Besides this, the growing demand for vitamin supplements and herbal medicines to treat PMS is offering a positive market outlook. Apart from this, the rising prevalence of PMS and premenstrual dysphoric disorder (PMDD), such as depression, panic attacks, and insomnia, due to hectic and sedentary working lifestyles is propelling the market growth. Moreover, the increasing adoption of oral contraceptives and ovarian suppression agents to treat PMS is bolstering the growth of the market. Furthermore, key manufacturers are investing in research and development (R&D) activities to introduce medications with minimal side effects that assist in maintaining pH balance in the body.

Premenstrual Syndrome Treatment Market 2023-2028 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• AbbVie Inc.
• BASF SE
• Bayer AG
• Reddy’s Laboratories Ltd
• Eli Lilly and Company.
• GlaxoSmithKline Plc.
• Lundbeck A/S
• Pfizer Inc.
• SHIONOGI & Co. Ltd.

The report has segmented the market on the basis on region, drug type, type, distribution channel.

Breakup by Drug Type:

• Analgesics
• Antidepressants
• Oral Contraceptives and Ovarian Suppression Agents
• Others

Breakup by Type:

• Prescription
• Prescription

Breakup by Distribution Channel:

• Hospital Pharmacies
• Drug Stores and Retail Pharmacies
• Online Stores

Breakup by Region:

• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/premenstrual-syndrome-treatment-market

Key highlights of the report:

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

IMARC Group
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group